The automated RT-PCR quantitative Xpert NPM1 mutation assay described herein thus has the potential to offer physicians, labs, and their patients a convenient tool for the accurate, timely management of NPM1-mutated AML patients. The gene discussed is NPM1; the disease is acute myeloid leukemia.